Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Intestinal Neoplasms 2Polyps 1Inflammatory Bowel Diseases 1Colonic Polyps 1Colonic Neoplasms 1

Interventions

Irinotecan 8Bevacizumab 8Fluorouracil 7Leucovorin 6Oxaliplatin 5Capecitabine 45,10-methylenetetrahydrofolic acid 3Radiotherapy 2Levoleucovorin 2Folfox protocol 2Drug Therapy 2Cetuximab 2Bisacodyl 2Aspirin 2Artesunate 2trametinib 1spartalizumab 1repotrectinib 1pralsetinib 1pembrolizumab 1nazartinib 1napabucasin 1guadecitabine 1encorafenib 1canakinumab 1camrelizumab 1apatinib 1alectinib 1aldesleukin 1XELOX 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Intestinal Neoplasms × Bisacodyl × Clear all
NCT05032794 2022-12-07

CriLiP

Parc Taulí Hospital Universitari

Phase NA Completed
553 enrolled

Intestinal Neoplasms

NCT01887158 2014-06-17

PEGOP

Ospedale Santa Maria delle Croci

Phase 4 Completed
116 enrolled

Intestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡